EUVIMEDEUVIMED entdecken
Crossref

Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131 I‐Radiolabeling

Kurls E Anwer iD, Basma M Essa, Adli A Selim iD, Galal H Sayed, Safaa S Shaban

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Kurls E Anwer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Heterocyclic Synthesis Lab, Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Azo Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work is designed to establish sustainable routes for the synthesis of new variable azo heterocyclic derivatives via the reaction of 2‐[(dicyanomethyl)diazinyl]benzoic acid 2 with different nucleophilic agents, including hydrazine derivatives (such as phenyl hydrazine and 2,4‐dinitrophenylhydrazine), acylhydrazines (e.g., benzoylhydrazine), nitrogen‐based nucleophiles (semicarbazide and thiosemicarbazide), oxygen‐containing reagents (hydroxylamine), as well as urea, thiourea, guanidine hydrochloride, and o ‐phenylenediamine. Both conventional heating and microwave approaches were used to furnish the desired heterocycles. The compounds exhibited potent antibacterial activity against Gram‐positive and Gram‐negative pathogens, outperforming fluconazole. The lead compound was successfully radiolabeled with 131 I in high yield (87.72% RCY). In vivo evaluation in an infection model demonstrated excellent pharmacokinetics, with specific uptake in infected tissue (13.7% ID/g at 1 h) and a high target‐to‐non‐target ratio (6.31). These findings underscore the theranostic potential of these azo compounds, positioning them as both antimicrobial agents and candidate radiotherapeutics for infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAzo CompoundsAnimalsMicrobial Sensitivity TestsIodine RadioisotopesGram-Positive BacteriaGram-Negative BacteriaStructure-Activity RelationshipMolecular StructureTissue DistributionMice

Stichwörter der Autor:innen

antibacterial activityazo‐compoundsbiodistributiongreen chemistryiodine‐131 radiolabeling

Substanzen

Anti-Bacterial AgentsAzo CompoundsIodine RadioisotopesIodine-131

Autor:innen und Institutionen

  • Heterocyclic Synthesis Lab, Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt.
  • Radioactive Isotopes and Generator Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt.
  • Labeled Compounds Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt.

ORCID-Profile: Kurls E Anwer, Adli A Selim

Zitieren

APA

Anwer, K. E., Essa, B. M., Selim, A. A., Sayed, G. H., & Shaban, S. S. (2026). Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131 I‐Radiolabeling. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70245

Vancouver

Anwer KE, Essa BM, Selim AA, Sayed GH, Shaban SS. Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131 I‐Radiolabeling. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70245

BibTeX
@article{Anwer2026,
  author = {Anwer, Kurls E and Essa, Basma M and Selim, Adli A and Sayed, Galal H and Shaban, Safaa S},
  title = {Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131 I‐Radiolabeling},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70245}
}
Kostenlos starten →